48 results on '"Nuzzo, Silvia"'
Search Results
2. Goat milk extracellular vesicles: Separation comparison of natural carriers for theragnostic application
3. Urinary Dickkopf-3 and Contrast-Associated Kidney Damage
4. Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
5. miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer
6. A method for the analysis of the oligomerization profile of the Huntington’s disease-associated, aggregation-prone mutant huntingtin protein by isopycnic ultracentrifugation.
7. 'No safe haven': Why the GATT 'regional exception' does not apply to technical barriers to trade.
8. Biomarkers of Contrast-Induced Nephropathy:: Which Ones are Clinically Important?
9. An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
10. The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
11. Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer
12. Paclitexel versus sirolimus-coated balloon in the treatment of coronary instent restenosis
13. Spinal neuronal activity and neuroinflammatory component in a mouse model of CFA-induced vestibulodynia
14. A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
15. Selection of RNA aptamers targeting hypoxia in cancer
16. Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer
17. Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study
18. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling
19. STENTYS coronary system: current status and future direction
20. Antifouling Strategies of Nanoparticles for Diagnostic and Therapeutic Application: A Systematic Review of the Literature
21. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation
22. Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics—A Systematic Review
23. miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer
24. Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
25. The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
26. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
27. Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
28. miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment
29. Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX)
30. Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer
31. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications
32. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
33. Biomarkers of Contrast-Induced Nephropathy:: Which Ones are Clinically Important?
34. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
35. Targeting Insulin Receptor with a Novel Internalizing Aptamer
36. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling
37. The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-κB to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells
38. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
39. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
40. Targeting Insulin Receptor with a Novel Internalizing Aptamer
41. Selection of RNA aptamers targeting hypoxia in cancer
42. Erratum: Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
43. Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
44. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.
45. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
46. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.
47. Targeting Insulin Receptor with a Novel Internalizing Aptamer.
48. The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.